London Pharma & Chemicals Holdings Ltd
Registered name: LONDON PHARMA & CHEMICALS HOLDINGS LTD
London Pharma & Chemicals Holdings Ltd made £108m revenue and £6.2m profit in the year to 31 Dec 2025. read from filing text
London Pharma & Chemicals Holdings Ltd’s revenue grew 1% to £108m in the year to 31 Dec 2025, with £6.2m profit and 2 employees. The company is classified under “activities of head offices” and is based in Borehamwood; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Borehamwood, East of England
- Age
- 16 yrs · since 2009
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | £102m | £110m | £107m | £108m |
| Cost of sales | £78.5m | £84.8m | £80.3m | £81m |
| Gross profit | £23.1m | £25.2m | £26.2m | £26.8m |
| Operating profit | £6.9m | £7.2m | £7.2m | £7m |
| Profit before tax | £7m | £8.3m | £7.7m | £7.5m |
| Profit after tax | £5.4m | £6.2m | £6m | £6.2m |
| Profit (best available) | £5.4m | £6.2m | £6m | £6.2m |
| Staff costs | £0 | £0 | £0 | £0 |
| Employees (average) | 2 | 2 | 2 | 2 |
| Ratios | ||||
| Profit margin | 5.3% | 5.6% | 5.6% | 5.7% |
| Gross margin | 22.7% | 22.9% | 24.6% | 24.9% |
| Revenue per employee | £50.8m | £55m | £53.3m | £53.9m |
| Profit per employee | £2.7m | £3.1m | £3m | £3.1m |
| Growth (year on year) | ||||
| Revenue growth | — | ▲8.3% | ▼3.2% | ▲1.2% |
| Profit growth | — | ▲14.8% | ▼3.7% | ▲3% |
| Headcount growth | — | 0% | 0% | 0% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £25m | £29m | £29m | £32.9m |
| Net assets | £40.6m | £46.6m | £50.8m | £58m |
| Fixed assets | £837k | £1.3m | £7.1m | £8.2m |
| Current assets | — | — | £71.2m | £76m |
| Debtors | £0 | £0 | £0 | £0 |
| Deferred income | £0 | £0 | £0 | £0 |
| Source | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2024 | FullAccounts · bulk data Sep 2025 | FullAccounts · bulk data Sep 2026 |
How the business works
- Profit margin
- 5.7%
- Profit ÷ revenue.
- Gross margin
- 24.9%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £53.9m
- Revenue ÷ average employees.
- Profit per employee
- £3.1m
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 7.6%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 0%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲14%
- Now £58m
- Cash at bank
- ▲14%
- Now £32.9m
- Headcount
- 0%
- Now 2
- Deferred income
- —
- Now £0
- Fixed assets
- ▲15%
- Now £8.2m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (1)
- London Pharma & Chemicals Group LtdRev. £687k · Profit £956k
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £6.2m), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.